Beta2-glycoprotein I (β2GPI) is the major target for autoimmune antibodies associated with antiphospholipid syndrome (APS), an autoimmune disease characterized clinically by thrombosis and recurrent pregnancy loss [1], [2], [3], [4]. The gene discussed is APOH; the disease is autoimmune polyendocrinopathy.